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Abstract
Background: Favourable trends in risk factor levels in the general population may partly explain the decline in
coronary heart disease (CHD) morbidity and mortality. Our aim was to present long-term national trends in
established risk factors for CHD.
Methods: Data were obtained from five data sources including several large scale population based surveys,
cohort studies and general practitioner registers between 1988 and 2012. We applied linear regression models to
age-standardized time trends to test for statistical significant trends. Analyses were stratified by sex and age
(younger <65 and older ≥65 years adults).
Results: The results demonstrated favourable trends in smoking (except in older women) and physical activity
(except in older men). Unfavourable trends were found for body mass index (BMI) and diabetes mellitus prevalence.
Although systolic blood pressure (SBP) and total cholesterol trends were favourable for older persons, SBP and total
cholesterol remained stable in younger persons.
Conclusions: Four out of six risk factors for CHD showed a favourable or stable trend. The rise in diabetes mellitus and
BMI is worrying with respect to CHD morbidity and mortality.
Keywords: Coronary heart disease, Risk factors, the Netherlands, Trends
Abbreviatons: BMI, Body mass index; CBS, Centraal Bureau voor de Statistiek; CHD, Coronary heart disease;
CI, Confidence interval; COR, Continue Onderzoek Rookgewoonten; EDTA, Ethylenediaminetetraacetic acid; GP, General
practitioner; HIS, GP information system; HNU, Huisartsen Netwerk Utrecht; ICPC, International Classification in Primary
Care; LASA, Longitudinal Aging Study Amsterdam; MET, Metabolic equivalent of task; NCD, Non-communicable
diseases; RIVM, National Institute for Public Health and the Environment; SBP, Systolic blood pressure; SE, Standard error;
SPSS, Statistical package for the social sciences; STIVORO, Stichting Volksgezondheid en Roken; TNS-NIPO, Taylor Nelson
Sofres Nederlands Instituut voor Publieke Opinie; UK, United Kingdom; VCPs, Dutch food consumption surveys
Background
Non-communicable diseases (NCD) are the main cause
of death worldwide. In the Netherlands, 90 % of deaths
are related to the main four NCDs (cancers 33 %, car-
diovascular diseases 29 %, chronic respiratory diseases
6 % and diabetes 2 %) [1]. Both modifiable risk factors
(behavioural) and non-modifiable risk factors (such as
age, gender, ethnicity, family history) can change the risk
for certain NCDs. Coronary heart disease (CHD) is a
major component of cardiovascular deaths. Systolic blood
pressure (SBP), cholesterol levels, body mass index (BMI),
smoking, diabetes and physical inactivity are major risk
factors for NCDs, but especially for cardiovascular disease.
CHD incidence, hospitalization, case-fatality and mortality
rates have markedly decreased in the Netherlands in the
last decades, as in other Western societies [2–4]. Declines
in CHD mortality could be attributed to improved medical
treatments and favourable changes in modifiable cardio-
vascular risk factors, which can be attained by an increase
in the use of cardiovascular drugs and revascularization
procedures and by improvements in lifestyle [5]. Previous
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international research suggests that 25–50 % of the CHD
mortality decline can be explained by changes in medical
treatments and the remaining 50–75 % by changes in
modifiable risk factors [6–8].
Monitoring cardiovascular risk factor trends is of great
importance as favourable changes in cardiovascular risk
factors can cause declines in CHD incidence rates, short-
term case-fatality rates (by less severe events), risks for re-
infarctions and mortality rates. Previous health policies
and strategies can be evaluated by monitoring parallel
changes in risk factors. Furthermore, valuable information
on past and current trends can help to design future inter-
ventions and address future policy questions.
Favourable trends for physical activity and smoking have
been observed for the Dutch population [9, 10], whereas
no consistent trends in cholesterol levels were seen [11].
Furthermore, substantial rises in the prevalence of obesity,
diabetes and small increases in blood pressure levels have
also been observed, which might attenuate the previously
observed decline in CHD incidence, hospitalization and
mortality rates [12–14]. However, the time span that was
covered by previous observations was outdated and
fragmented. Furthermore, older adults (over 70 years)
were not included, despite that the largest burden of CHD
is in this age group. We aimed to provide a descriptive
analysis of age-sex specific time trends in systolic blood
pressure (SBP), body mass index (BMI), total cholesterol
levels, diabetes mellitus, physical activity and smoking
prevalence in the general population including ages up to
85 years between 1988 and 2012.
Methods
Data were obtained from five data sources including
cohort studies, surveys and general practitioner registers,
that were representative for the Dutch population.
Characteristics of the five data sources that we used are
presented in Table 1.
Data sources
Systolic blood pressure (SBP)
Data on SBP were obtained from the National Institute
for Public Health and the Environment (RIVM)
Doetinchem Cohort study for individuals under 65 years
of age [15]. The Doetinchem Cohort study started in
1987. During the period 1987–1991 baseline data was
obtained from 7,769 individuals, aged 20–59 years at
baseline. The study comprised a physical examination for
measurements of body weight, height, systolic and
diastolic blood pressure, a non-fasting blood sample (total
cholesterol) and questionnaire information on lifestyle and
diet. The overall response rate at baseline was 62 %.
Follow-up examinations were carried out every 5 years,
with response rates varying between 75 and 80 %. Blood
pressure was measured twice in each examination in sit-
ting position after 2 min of rest. The mean value of two
measurements was used in the analyses. Blood pressure in
examination 4 was measured with a different device and
patients sat in a slightly different position. Random coeffi-
cient analyses were used to obtain a correction factor for
examination 4 to make blood pressure values at the
different examinations comparable [16].
For individuals aged 65 years or above we used data
from the Longitudinal Aging Study Amsterdam (LASA)
[17]. LASA is an ongoing study focusing on physical,
emotional, cognitive, and social functioning in older
adults. Data collection started in 1992, from the popula-
tion registries of 11 municipalities in the Netherlands.
During the period 1992–1993 baseline data was obtained
from 3,107 individuals, aged 55–85 years. Every examin-
ation consisted of two parts, a main examination and a
medical interview. The initial response rate was 60 %.
Follow-up examinations were carried out every 3 years
since then. The response rates for follow-up measure-
ments were around 85 %. In 2002–2003, a new cohort was
sampled (n = 1,002, 55–65 years). The initial response rate
Table 1 Characteristics of the five data sources used in this study
Data source Risk factor Study design Response rate N Age range Time period
Doetinchem Cohort Study SBP <65 years






7769 at baseline 20–59 Years
at baseline
1987–2007
LASA SBP ≥65 years






3107 at baseline 55–85 Years
at baseline
1995–2009





HNUa Diabetes mellitus GP Register/Dynamic
cohort study
n/a 70,854 in 1996
100,359 in 2012
All ages included 1996–2012





SBP systolic blood pressure, BMI body mass index, LASA Longitudinal Aging Study Amsterdam, STIVORO Stichting Volksgezondheid en Roken, HNU Huisartsen
register Utrecht, GP general practitioner, CBS Centraal Bureau voor de Statistiek
aGP register Continue Morbiditeits Registratie-Nijmegen, GP register Registratienet Huisartsenpraktijken-Limburg, the Doetinchem Cohort Study and LASA were
used to adjust diabetes prevalences from HNU (see Additional file 1)
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of the new cohort was 55 %. Both samples were combined
for the present analyses. Blood pressure was measured in
sitting position, three times in the first examination, once
in examination 2 and 3, three times in examination 4 and
5 and four times in examination 6. The mean value of the
measurements was used in the present analyses. Blood
pressure in the first examination was measured with a dif-
ferent device than in the other examinations. Therefore,
we only included data on blood pressure of examinations
2 to 6.
Total cholesterol
Data on total cholesterol was obtained from the
Doetinchem Cohort study for individuals aged 35–64
years and from LASA for individuals aged 65 years or
over. Total cholesterol was measured in all 4 examina-
tions in the Doetinchem Cohort Study, until 1998 in
non-fasting EDTA-plasma and from 1998 onwards in
serum at a lipid reference laboratory, using standardized
enzymatic methods. Total cholesterol was measured in
examination 2 and 6 in LASA, in non-fasting EDTA
plasma samples stored at −80 °C, using an enzymatic
(CHOD-PAP) colorimetric test.
BMI
Data on BMI was obtained from the Doetinchem Cohort
Study for individuals aged 35–64 years and from LASA
for individuals aged 65 years and over. Weight and
height of participants in the Doetinchem Cohort Study
were measured with participants wearing light indoor
clothing with emptied pockets and without shoes. Body
weight was measured to the nearest 0.1 kg on calibrated
scales and height to the nearest 0.5 cm. BMI in the
Doetinchem-study was calculated as weight minus 1 kg
to adjust for clothing, divided by height squared (kg/m2).
Weight and height of participants in LASA were mea-
sured with participants wearing underwear. Some partic-
ipants wore clothes or a corset during the measurement.
The adjustment for clothing in LASA was minus 1 kg
for clothing and/or minus 1 kg for a corset.
Smoking
Smoking data was obtained from the Dutch expert
centre on tobacco control STIVORO (Stichting Volksge-
zondheid en Roken, STIVORO, TNS-NIPO Continue
Onderzoek Rookgewoonten (COR) 1988–2011). COR
collects online-data throughout the year of 20,000 adults
aged 15 years and over about the number of people who
smoke, the characteristics of smokers and smoking behav-
iour. The response rate was 70 % in 2011. The question in
the survey we used was “Do you smoke (sometimes)?”
(yes/no). This particular question has not changed during
the study period.
Diabetes mellitus
Diabetes mellitus data was obtained from the general
practitioner (GP) registry ‘Huisartsen Netwerk Utrecht’
(HNU). The registry data were collected from 1996 to
up to 2012. HNU is a GP registry of 5 GP practices
comprising about 100,000 patients in 2012. We defined
diabetes mellitus as an International Classification in
Primary Care (ICPC)-code T90 mentioned in the elec-
tronic patient record. Information was collected from
Huisartsen Informatie Systeem data (HIS: GP informa-
tion system). Since the information on diabetes mellitus
dealt with previous or current diagnosis of diabetes
mellitus, the time window for patients in the beginning
of the registry was shorter than for those who were entered
later in the registry. As a consequence, the estimates of dia-
betes mellitus prevalence in the beginning years of the
study period were underestimated. To adjust for underesti-
mation, we created an adjustment factor based on the aver-
age relative increase in diabetes prevalence between 1997
and 2007 that we estimated using all available data sources
(GP register Continue Morbiditeits Registratie-Nijmegen,
GP register Registratienet Huisartsenpraktijken-Limburg,
the Doetinchem Cohort Study and LASA). More informa-
tion on the calculation of the adjustment factor can be
found in the Additional file 1.
Physical activity
The ‘Centraal Bureau voor de Statistiek Gezondheidsen-
quete’ is a health survey using a questionnaire on various
health aspects performed in inhabitants of the Netherlands.
Information was available on physical activity from 2001 to
2011 from about 15,000 individuals each year. The response
rates varied between 60 and 65 %. Physical activity was de-
fined as self-reported compliance to the Dutch physical ac-
tivity standard entitled ‘Norm gezond bewegen’. Individuals
of 18 to 54 years of age were classified as active when they
participated in activities with a Metabolic Equivalent of
Task (MET) ≥4 for at least 30 min a day for at least 5 days
a week. Individuals aged 55 years or over were classified as
active when they participated in activities with a Metabolic
Equivalent of Task (MET) ≥3 for at least 30 min a day for
at least 5 days a week.
Data analyses
We applied linear regression models to the age-
standardized trends to investigate whether trends over
time were statistically significant. Statistical significance
was based on a two-sided P-value less than 0.05. It was
not possible to calculate P-values for trends in total chol-
esterol ≥65 years because we only had two measurement
points available. Trends in risk factors were presented sep-
arately for men and women and standardized to the age
distribution of the Dutch population of 2010. Standardisa-
tion was done using a direct method with 10 year age
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groups. Trends in continuous risk factors (SBP, total choles-
terol and BMI) were presented as age-standardized mean
values. To calculate 95 % confidence intervals (CI) for
continuous risk factors we used 1.96 times the standard
error (SE) of the mean either side of the estimate. Trends
in dichotomous risk factors (smoking, diabetes and physical
activity) were presented as prevalence proportions (%). To
calculate 95 % CI for dichotomous risk factors we used 1.96






Factor p comprises the prevalence proportion of the
risk factor and factor n the sample size. Data were ana-
lysed using SPSS version 20 and Microsoft Excel 2007.
Results
Age-sex specific trends are presented in Fig. 1. Results
are summarized in Table 2.
SBP
Between 1987–1992 and 2003–2007, SBP remained stable
over time in persons <65 years, with fluctuation in men
between 127.9 mmHg and 131.1 mmHg (P= 0.15), and in
women between 122.4 mmHg and 125.7 mmHg (P = 0.59).
In persons ≥65 years, SBP declined in men from 152.5 mmHg
in 1995/1996 to 141.9 mmHg in 2008/2009 (P < 0.01) and in
women from 151.7 mmHg to 139.7 mmHg (P= 0.04).
Total cholesterol
Between 1987–1992 and 2003–2007, total cholesterol
remained stable over time in men and women <65 years
with fluctuation between 5.5 mmol/l and 5.8 mmol/l
(P = 0.15 in men and P = 0.19 in women). In persons
≥65 years, total cholesterol declined in men from
5.5 mmol/l in 1995/1996 to 5.1 mmol/l in 2008/2009
and in women from 6.0 mmol/l to 5.7 mmol/l.
BMI
Between 1987–1992 and 2003–2007, BMI increased in men
<65 years from 25.8 kg/m2 to 26.6 kg/m2 (P < 0.01) and in
women from 25.6 kg/m2 to 25.9 kg/m2 (P= 0.02). In persons
≥65 years, BMI increased in men from 25.7 kg/m2 in
1992/1993 to 26.9 kg/m2 in 2008/2009 (P = 0.001) and
remained stable in women from 27.5 kg/m2 to 27.9 kg/m2
(P = 0.052).
Smoking prevalence
Between 1988 and 2011, the prevalence of smoking de-
creased in men <65 years from 42 to 35 % (P < 0.001)
and in women from 31 to 24 % (P < 0.001). In persons
≥65 years, the prevalence of smoking decreased in men
from 35 % in 1988 to 15 % in 2011 (P < 0.001) and
remained stable over time in women around 11–13 %
(P = 0.75).
Diabetes mellitus prevalence
Between 1995 and 2012, the prevalence of diabetes in-
creased in men <65 years from 2.1 to 4.0 % (P < 0.001)
and in women from 2.0 to 3.5 % (P < 0.001). In persons
≥65 years, the prevalence of diabetes increased in men
from 8.7 % in 1995 to 24.1 % in 2012 (P < 0.001) and in
women from 12.2 to 22.1 % (P < 0.001).
Physical activity
Between 2001 and 2011, the proportion that complied to
the Dutch physical activity standard increased in men
<65 years from 50 to 56 % (P < 0.001) and in women
from 53 to 58 % (P < 0.001). In persons ≥65 years, the
proportion that complied to the Dutch physical activity
standard remained stable over time in men around 68–
69 % (P = 0.64) and increased in women from 46 to 58 %
(P < 0.001).
Discussion
This study adds important information about long-term
national trends in CHD risk factors in the Netherlands
between 1988 and 2012. The results demonstrated
favourable trends in smoking (except in women ≥65 years)
and physical activity (except in men ≥65 years). Unfavour-
able trends were found for BMI and diabetes prevalence.
Although SBP and cholesterol trends were favourable for
those aged 65 years or over, SBP and cholesterol remained
stable in men and women <65 years.
Our results are consistent with results from several
other studies performed in Western societies during ap-
proximately the same time frame. Declines in smoking
and cholesterol levels have been apparent in most western
European countries [18–23]. Increases in body mass index
and diabetes mellitus have been reported in many estab-
lished and emerging economies [6, 8, 23–25]. Information
on adherence to the physical activity recommendation is
more limited, but generally shows improvement over time
[21, 22]. In countries surrounding the Netherlands de-
creasing trends in SBP been reported across all age groups
[18, 19, 21, 23, 26]. Despite the similarity of the other risk
factor trends in these countries, we did not observe a de-
cline in SBP in persons aged 65 years or below.
There are several factors and health policies that could
have contributed to the observed trends in cardiovascular
risk factors: i) nationwide campaigns to raise awareness
and promote healthy behaviour (primary prevention),
ii) screening and case-finding in high risk populations
(primary prevention), iii) cardiovascular risk manage-
ment in patients and high-risk groups following the
most recent guidelines (primary and secondary preven-
tion), iv) government policies, measures, restrictions and
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changes in for example product availability or content
(primary prevention).
Decreasing trends in blood pressure and cholesterol,
especially in older people, may be due to the increase in
use of blood pressure and cholesterol lowering drugs [5].
A nationwide salt campaign started in 2006 (at the end
of our study period) by the Dutch Consumer Organisa-
tion and salt content in bread was reduced by legislation.
However, analyses of the Doetinchem Cohort Study
showed that the salt intake in persons under 65 years
did not decline between 2006 and 2010 [27]. The UK
initiated a nationwide salt reduction programme in
2003/2004. As expected, the observed declines in SBP at
population-level are larger in the UK than in the
Netherlands [21, 23]. The increase in BMI may explain
part of the lack of decline in systolic blood pressure in
those under 65 years, and is also likely to explain the in-
crease in diabetes. Although total fat intake decreased,
saturated fat intake remained quite stable [28]. Data
from Dutch food consumption surveys (VCPs) showed
that the intake of trans fatty acids has decreased over
time, from 4.5 % in 1987/1988 to 0.5 % in 2007/2010 in
the Netherlands, a trend that may have affected the
population total cholesterol level beneficially [29, 30].
The dramatic increase in diabetes prevalence likely re-
flects a combination of an increase in new cases and
more active screening for diabetes by general practi-
tioners resulting in more undetected diabetes mellitus
patients being identified.
The Dutch government has formulated several objec-
tives in the last decades, aimed at diminishing the problem
of obesity, but none of these objectives have been reached.
Nevertheless, this study showed that the increase in BMI
in older women levelled off. Several nationwide campaigns
to raise awareness on overweight and promote physical ac-
tivity were organised during the study period. An evalu-
ation of a large 5-year mass media campaign (2002–2007)
on overweight and physical activity showed that despite
the high levels of free publicity and campaign exposure,
the campaign was not strong enough to provoke
substantial changes in important predictors of behaviour
change [31]. Joint efforts of the government, food industry,
retail and NGO’s since 2005 resulting in a covenant on
overweight are promising.
The decline in smoking may in part be attributed to
the increasing awareness and education level in the
Netherlands on the adverse effects of smoking. Fur-
thermore, the Dutch expert centre on tobacco control
STIVORO took the lead in launching an intensive
media-supported millennium smoking cessation cam-
paign. It was estimated that 600.000 people (>15 % of
smokers) attempted to quit smoking at the millennium
and 12 % managed to abstain for more than 1 year.
Smoke-free legislation started in the Netherlands in
2004 with a workplace smoking ban and in 2008 with
the hospitality industry ban. An evaluation study
observed a decline in smoking prevalence after the
implementation of the workplace ban, but not after
the hospitality industry smoking ban [32]. Further-
more, tobacco tax increases (2001, 2004, and 2008) were
implemented in the Netherlands and likely have contrib-
uted to the decline in smoking. A systematic review
showed that a 10 % increase in price increased cessation
rates in adults with 3–5 % [33].
Our study is the first to show an overview of Dutch
time trends in all major risk factors for CHD, including
young and older adults. Ideally, all risk factors would be
measured repeatedly over time in one large cohort or
survey that is representative for the general population.
Unfortunately, data on risk factors is scattered in the
Netherlands, and thus we had to use the best data
available from different data sources. The size, quality
and methodology of these studies differed. Trends in
SBP, cholesterol and BMI were estimated by repeated
measurements within one cohort. Response rates varied
over time, which may have resulted in biased trend esti-
mates. Yet previous research with similar data showed
limited selective dropouts [34]. Nevertheless, absolute
levels of risk factors could be different from the general
population since those who volunteered to take part in
studies tend to be healthier than those who do not.
Absolute differences in risk factors over time could be
smaller in healthier cohorts compared to the general
population. Moreover, lower baseline levels of risk
factors will leave less room for improvement. Also, self-
reporting could have underestimated absolute levels of
smoking and overestimated physical activity levels. This
misclassification is expected to be constant over time
and therefore not influencing our trend analyses.
Trends in risk factors are generally used for evaluating
public health policies and interventions and to estimate the
changes in CHD risk in a population. In the Netherlands,
we recently showed a steep decline in incidence of acute
myocardial infarction, a major contributor to CHD. From
Table 2 Dutch time trends in cardiovascular risk factors: main
findings of the analyses
Adults <65 years Elderly≥ 65 years
Men Women Men Women
SBP = = ↓ ↓
Total cholesterol = = ↓ ↓
BMI ↑ ↑ ↑ =
Smoking ↓ ↓ ↓ =
Diabetes ↑ ↑ ↑ ↑
Physical activity ↑ ↑ = ↑
SBP systolic blood pressure, BMI body mass index
↑, increasing time trend. ↓, decreasing time trend. =, stable time trend
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1998 to 2007 the decline in incidence was 38 % in men and
32 % in women [2]. Although BMI and diabetes showed
unfavourable trends, the steep decline in incidence of acute
myocardial infarction suggests that the balance between
favourable and unfavourable trends goes in favour of CHD
risk reduction. However, the poorer health of the younger
generation is a rising threat for the current decline in
cardiovascular disease and therefore monitoring of
population-wide risk factor levels is highly warranted
[34]. We advise to integrate and harmonize the different
Dutch data sources from cohorts, surveys and registers.
Conclusion
In conclusion, four out of six risk factors for CHD
showed a favourable or stable trend. The rise in diabetes
mellitus and BMI is worrying. These trends need to be
monitored and addressed by interventions to ensure a
continuing decline in CHD morbidity and mortality.
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